Neoadjuvant Immunotherapy in Operable Colon Cancer: Opportunities and Challenges Totadri DhimalFergal J. Fleming Colorectal Cancer 23 February 2025 Pages: 3049 - 3051
Invited Editorial: “Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer—A Multicenter Retrospective Study,” by Nozawa et al. Tarik Sammour Colorectal Cancer 26 February 2025 Pages: 3052 - 3053
Surgical Intervention for Colorectal Neuroendocrine Tumor: Not So Fast Clifford S. Cho Endocrine Tumors 24 February 2025 Pages: 3054 - 3055
Finding the Correct Divide: Left Upper Lobe Segmentectomy Versus Lobectomy Tyler R. Grenda Thoracic Oncology and Esophageal Cancer 04 February 2025 Pages: 3056 - 3057
Balancing Local and Systemic Control in Esophageal Cancer Thomas KimDian Wang Thoracic Oncology and Esophageal Cancer 12 January 2025 Pages: 3058 - 3059
Questioning the Role of BRAF V600E as a Prognostic Indicator in Papillary Thyroid Carcinoma Mahsa Javid Translational Research Open access 05 February 2025 Pages: 3060 - 3061
Sentinel Node Mapping with Blue Dye Injection after Lumpectomy Specimen Removal: Implications for Fluorescence-Guided Breast Surgery Heidi S. Santa CruzJulia N. ShannoBarbara L. Smith ASO Research Letter Open access 14 December 2024 Pages: 3062 - 3064
INSIGHT: A Phase III Trial of Ripretinib Versus Sunitinib in Patients with Advanced GIST with KIT Exon 11 and Exon 17/18 Mutations Who Were Previously Treated with Imatinib Carolina LarrainTracey PuSuzanne George ASO Research Letter Open access 05 February 2025 Pages: 3065 - 3067
Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair: Modeling Oncological Outcomes and Numbers Needed to Treat Arezo KananiTorhild VeenKjetil Søreide Colorectal Cancer Open access 30 December 2024 Pages: 3068 - 3077
Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study Julia HaneveltRichard M. BrohetWouter H. de Vos Tot Nederveen Cappel Colorectal Cancer 23 January 2025 Pages: 3078 - 3088
Predictors of Pathologic Non-response to Neoadjuvant Approaches in Locally Advanced Rectal Cancer Jyi Cheng NgAnnaclara SileoDavid W. Larson Colorectal Cancer 07 February 2025 Pages: 3089 - 3097
Risk Factors for Regrowth After Nonoperative Management for Rectal Cancer Neal BhutianiKentaro OchiaiAbhineet Uppal Colorectal Cancer 09 February 2025 Pages: 3098 - 3105
ASO Author Reflections: Pushing the Boundaries of Local Excision: How Does the Risk of Lymph Node Metastases Compare to Those Associated with Major Surgery in T2 Colon Cancer Patients? Julia HaneveltRichard M. BrohetWouter H. de Vos tot Nederveen Cappel ASO Author Reflections 13 February 2025 Pages: 3106 - 3107
ASO Visual Abstract: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair—Modelling Oncological Outcomes and Numbers Needed to Treat Arezo KananiTorhild VeenKjetil Søreide ASO Visual Abstract 23 January 2025 Pages: 3108 - 3109
ASO Visual Abstract: Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study Julia HaneveltRichard M. BrohetWouter H. de Vos tot Nederveen Cappel ASO Visual Abstract 03 March 2025 Pages: 3110 - 3111
Impact of Delayed Surgery on Local Colorectal Neuroendocrine Tumors: Is Surveillance a Feasible Option? Benjamin C. GreenspunDaniel Aryeh MetzgerBrendan M. Finnerty Endocrine Tumors 31 January 2025 Pages: 3112 - 3118
The Landmark Series: Extent of Surgery for Low-Risk Differentiated Thyroid Cancer Timothy M. UllmannJulie A. Sosa Endocrine Tumors Open access 26 February 2025 Pages: 3119 - 3125
The Landmark Series: Management of Primary Hyperparathyroidism Jordan M. BroekhuisDouglas L. FrakerJason B. Liu Endocrine Tumors 01 March 2025 Pages: 3126 - 3134
ASO Author Reflections: Active Surveillance for Local Colorectal Neuroendocrine Tumors—Patient Selection is Paramount Benjamin C. GreenspunDaniel A. MetzgerBrendan M. Finnerty ASO Author Reflections 18 February 2025 Pages: 3135 - 3135
ASO Visual Abstract: The Impact of Delayed Surgery on Local Colorectal Neuroendocrine Tumors—Is Surveillance a Feasible Option? Benjamin C. GreenspunDaniel Aryeh MetzgerBrendan M. Finnerty ASO Visual Abstract 06 March 2025 Pages: 3136 - 3137
Outcomes of Intraoperative Radiotherapy for Locally Advanced Adenocarcinoma of the Esophagogastric Junction After Neoadjuvant Therapy: A Single-Arm, Phase 1 Trial From the Chinese National Cancer Center Guochao ZhangLong ZhangYong Li Thoracic Oncology and Esophageal Cancer 08 December 2024 Pages: 3138 - 3146
Positive Lymph Node Status Before and After Neoadjuvant Chemoradiotherapy Improves Prediction of Disease-Free Survival in Esophageal Squamous Cell Carcinoma Patients Xu HuangZitao JianMiao Lin Thoracic Oncology and Esophageal Cancer 30 January 2025 Pages: 3147 - 3156
Conversion from Radical Esophagectomy to Definitive Chemoradiotherapy After Neoadjuvant Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: Treatment Options Based on Chemotherapy Response Kiyoshi NaritaEiji HigakiYasuhiro Shimizu Thoracic Oncology and Esophageal Cancer 14 February 2025 Pages: 3157 - 3166
Time Trends in Survival After Surgery for Esophageal Cancer in a National Population-Based Study in Sweden Ellinor LundbergFredrik MattssonJesper Lagergren Thoracic Oncology and Esophageal Cancer Open access 17 February 2025 Pages: 3167 - 3174
The Landmark Series: Advances in Preoperative Mediastinal Lymph Node Staging for Non-small Cell Lung Cancer (NSCLC) Alison S. BaskinKatemanee BurapachaisriJeffrey B. Velotta Thoracic Oncology and Esophageal Cancer Open access 01 March 2025 Pages: 3175 - 3186
ASO Author Reflections: Preoperative Mediastinal Lymph Node Staging for Non-small Cell Lung Cancer: Where Do We Go from Here? Alison S. BaskinJeffrey B. Velotta ASO Author Reflections Open access 17 February 2025 Pages: 3187 - 3188
Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma Nazia RiazAnne HuibersRoger Olofsson Bagge Melanoma and Cutaneous Oncology Open access 01 February 2025 Pages: 3189 - 3197
Better-Defined Morbidity of Sentinel Lymph Node Biopsy in Patients with Melanoma Mason GonzalesKent GroshLaurence E. McCahill Melanoma and Cutaneous Oncology 13 February 2025 Pages: 3198 - 3202
Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with Melanoma Anne HuibersStanley P. Leong on behalf of the Sentinel Lymph Node Working Group Melanoma and Cutaneous Oncology Open access 10 March 2025 Pages: 3203 - 3211
The Landmark Series: Melanoma and Adjuvant Therapy Michael C. LoweKeith A. DelmanDavid W. Ollila Melanoma and Cutaneous Oncology 11 March 2025 Pages: 3212 - 3215
ASO Author Reflections: Nevus-Associated Melanoma: A Prognostically Distinct Entity Nazia RiazRoger Olofsson Bagge ASO Author Reflections Open access 18 February 2025 Pages: 3216 - 3217
ASO Visual Abstract: Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma Nazia RiazAnne HuibersRoger Olofsson Bagge ASO Visual Abstract 08 March 2025 Pages: 3218 - 3219
Leveraging Deep Learning in Real-Time Intelligent Bladder Tumor Detection During Cystoscopy: A Diagnostic Study Zixing YeYingjie LiZhigang Ji Urologic Oncology Open access 06 March 2025 Pages: 3220 - 3226
ASO Author Reflections: Artificial Intelligence-Augmented Detection of Bladder Tumors Zixing YeYingjie LiZhigang Ji ASO Author Reflections 02 March 2025 Pages: 3227 - 3228
ASO Visual Abstract: Leveraging Deep Learning in Real-Time Intelligent Bladder Tumor Detection During Cystoscopy—A Diagnostic Study Zixing YeYingjie LiZhigang Ji ASO Visual Abstract 11 March 2025 Pages: 3229 - 3229
ASO Visual Abstract: Perioperative Complications and In-Hospital Mortality in Radical Nephroureterectomy Patients with Heart Valve Replacement Francesco Di BelloNatali Rodriguez PeñarandaPierre I. Karakiewicz ASO Visual Abstract 21 January 2025 Pages: 3230 - 3231
ASO Visual Abstract: The Long-Term Functional and Oncologic Outcomes of Kidney-Sparing Surgery in Upper-Tract Urothelial Carcinoma Yu-Chieh WangJian-Ri LiChiann-Yi Hsu ASO Visual Abstract 17 December 2024 Pages: 3232 - 3233
Preoperative MRI to Predict Upstaging of DCIS to Invasive Cancer at Surgery Sara H. JavidAnum S. KazerouniHabib Rahbar Breast Oncology 28 January 2025 Pages: 3234 - 3243
Trends in Atypical Ductal Hyperplasia Diagnosis and Upgrade: A 20-Year Experience and Impact of MRI Use on Upgrade Rates Shruti ZaveriSusie X. SunIsabelle Bedrosian Breast Oncology 28 January 2025 Pages: 3244 - 3251
Ongoing Symptoms and Concerns Experienced by Low-Risk Breast Cancer Survivors Following Active Treatment Jessica R. SchumacherJennifer L. TucholkaHeather B. Neuman Breast Oncology 29 January 2025 Pages: 3252 - 3259
Protective Factors Associated with Normal Lymphatic Function After Axillary Lymph Node Dissection for Breast Cancer Treatment Janet C. Coleman-BelinJonathan RubinMichelle Coriddi Breast Oncology 03 February 2025 Pages: 3260 - 3267
The American Joint Committee on Cancer (AJCC) Breast Cancer Staging, Eighth Edition, is more Reflective of Cancer Biology than the Seventh Edition Jessica YoungMariko AsaokaKazuaki Takabe Breast Oncology 07 February 2025 Pages: 3268 - 3277
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial Judy C. BougheyHongmei Yuthe I-SPY2 Locoregional Working Group Breast Oncology 13 February 2025 Pages: 3278 - 3291
Factors Associated with Nodal Positivity Following Neoadjuvant Systemic Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI B. Bersu OzcanFirouzeh K. ArjmandiBasak E. Dogan Breast Oncology 13 February 2025 Pages: 3292 - 3301
Outcomes in Women Undergoing Combined Breast, Plastic, and Gynecologic Surgery Yancey E. Warren Jr.Thor S. SteadDavid A. Edmonson Breast Oncology 13 February 2025 Pages: 3302 - 3308
Racial and Ethnic Differences in Breast Inflammation and Its Association with Lymphedema Risk After Axillary Lymph Node Dissection Arielle RobertsAdana-Christine CampbellAndrea V. Barrio Breast Oncology 19 February 2025 Pages: 3309 - 3316
Disparities in Stage at Presentation for Disaggregated Asian American, Native Hawaiian, and Pacific Islander Patients with Breast Cancer Advait ThaplooKhushi KohliFumiko Chino Breast Oncology 01 March 2025 Pages: 3317 - 3330
ASO Author Reflections: Sentinel Lymph Node Biopsy in Node-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Considerations and Emerging Evidence Basak Dogan ASO Author Reflections 07 March 2025 Pages: 3331 - 3332
ASO Author Reflections: What’s Inflammation Got to Do With It? Understanding the Pathogenesis of Lymphedema After Axillary Surgery Arielle N. RobertsAndrea V. Barrio ASO Author Reflections 13 March 2025 Pages: 3333 - 3334
ASO Author Reflections: The Financial Impact of Delayed and Forgone Care Among Patients with Breast Cancer Kriyana P. ReddyOluwadamilola M. Fayanju ASO Author Reflections Open access 11 February 2025 Pages: 3335 - 3336
